Henshaw Capital »

Ascendis Pharma AS shares owned by Henshaw Capital

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by Henshaw Capital from 13F filings

Historical chart of Henshaw Capital investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by Henshaw Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by Henshaw Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $555k 2.1k 266.72

More positions owned by Henshaw Capital

NVIDIA Corporation (NVDA)
Apple (AAPL)
Eli Lilly & Co. (LLY)
Applied Materials (AMAT)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Ge Aerospace Com New (GE)
Ishares Msci Equal Weite (EUSA)
Palo Alto Networks (PANW)
Amazon (AMZN)
Ge Vernova (GEV)
Marvell Technology (MRVL)
Vanguard Scottsdale Fds Vng Rus2000idx (VTWO)
Microsoft Corporation (MSFT)

View all positions for Henshaw Capital

Top funds holding Ascendis Pharma AS

RA Capital Management
venBio Select Advisor
Westfield Capital Management Company
Jupiter Topco
FMR
Artisan Partners Limited Partnership
BlackRock
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Franklin Resources
Wellington Management Company
T. Rowe Price Associates
American Century Companies
Perceptive Advisors
Principal Financial Group

View all funds holding Ascendis Pharma AS